Benjamin Kunstler

Bain Capital LLC is one of the world's leading private investment firms managing approximately $66 billion in assets under management. Their affiliated advisors make private equity, public equity, leveraged debt asset, venture capital, and absolute return investments across multiple sectors, industries, and asset classes. Since their inception, their competitive advantage has been grounded in a people-intensive, value-added investment approach that has enabled the firm to deliver industry-leading returns for their investors.

STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany.

Bain Capital Private Equity (Europe) LLP engages in the provision of investment advisory services. The company was founded on November 12, 2012 and is headquartered in London, the United Kingdom.

Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands.

Centrient Holding BV operates as a special purpose entity. The private company is based in Rotterdam, Netherlands. and has subsidiaries in Netherlands. The Dutch company was founded in 1869. Rex Clements has been the CEO of the company since 2020.